Serum Prolidase Activity and the Role of Leptin in Osteomalacia

NCT05716750 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2023-02-14

No results posted yet for this study

Summary

Evaluation of the change of serum Prolidase and Leptin values in the diagnosis and follow-up of osteomalacia and its clinical usability

Conditions

  • Osteomalacia

Interventions

DIETARY_SUPPLEMENT

Vitamin D

50,000 IU vit D treatment for 8 weeks

Sponsors & Collaborators

  • TUĞBA ŞAHBAZ

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-15
Primary Completion
2023-04-30
Completion
2023-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05716750 on ClinicalTrials.gov